| Literature DB >> 27367568 |
S E Verleden1, R Vos2, E Vandermeulen2, D Ruttens2, H Bellon2, T Heigl2, D E Van Raemdonck2, G M Verleden2, V Lama3, B D Ross4, C J Galbán4, B M Vanaudenaerde2.
Abstract
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation. Air trapping and mosaic attenuation are typical radiological features of BOS; however, quantitative evaluation remains troublesome. We evaluated parametric response mapping (PRM, voxel-to-voxel comparison of inspiratory and expiratory computed tomography [CT] scans) in lung transplant recipients diagnosed with BOS (n = 20) and time-matched stable lung transplant recipients (n = 20). Serial PRM measurements were performed prediagnosis, at time of BOS diagnosis, and postdiagnosis (Tpre , T0 , and Tpost , respectively), or at a postoperatively matched time in stable patients. PRM results were correlated with pulmonary function and confirmed by microCT analysis of end-stage explanted lung tissue. Using PRM, we observed an increase in functional small airway disease (fSAD), from Tpre to T0 (p = 0.006) and a concurrent decrease in healthy parenchyma (p = 0.02) in the BOS group. This change in PRM continued to Tpost , which was significantly different compared to the stable patients (p = 0.0002). At BOS diagnosis, the increase in fSAD was strongly associated with a decrease in forced expiratory volume in 1 s (p = 0.011). Micro-CT confirmed the presence of airway obliteration in a sample of a BOS patient identified with 67% fSAD by PRM. We demonstrated the use of PRM as an adequate output to monitor BOS progression in lung transplant recipients. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: bronchiolitis obliterans (BOS); clinical research/practice; diagnostic techniques and imaging: computed tomography; lung transplantation/pulmonology
Mesh:
Year: 2016 PMID: 27367568 PMCID: PMC5083149 DOI: 10.1111/ajt.13945
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086